1st TIF Pan American Conference and 2nd RAIN Summit: A Milestone of Hope
Thalassaemia International Federation (TIF) shared a grateful post on LinkedIn:
”What an unforgettable journey in Washington D.C.!
As we look back on the 1st TIF Pan American Conference and the 2nd RAIN Summit, we are deeply grateful to our incredible Sponsors who helped turn this vision into reality.
Your generous support empowered vital conversations and new connections among the Thalassaemia, SCD, and Rare Anaemias communities across the Americas.
Thank you for standing with us — for care, for science, for hope!”
The 1st TIF Pan American Conference and 2nd RAIN Summit in Washington D.C. marked an unforgettable milestone for the Thalassaemia, SCD, and Rare Anaemias communities.
TIF thanked all the sponsors: Agios Pharmaceuticals, Bristol Myers Squibb, Vertex Pharmaceuticals, bluebird bio, Chiesi Global Rare Diseases, Novo Nordisk and Sanofi.
Thanks to the support of dedicated sponsors, vital conversations and new collaborations flourished—advancing care, science, and hope across the Americas.
Do not miss the latest updates on the waves in the hematology field, read Hemostasis Today.
-
Oct 16, 2026, 13:59Aya Akmal Amin: Antiphospholipid Syndrome Management and Risk Stratification
-
Oct 16, 2026, 13:10Emanuel Sueldo: CAHT 2026 Celebrates Scientific Progress and Team Achievements
-
Oct 16, 2026, 13:05Maha Othman: Queen’s Health Sciences Advances CAT Risk Models and Pediatric ISTH-BAT Cut-Offs
-
Oct 16, 2026, 13:03Thrombosis Awareness Must Lead to Timely Action – Roche
-
Oct 16, 2026, 12:49Wolfgang Miesbach: 5-Year CBDR Data Confirms Emicizumab Safety and Efficacy in Hemophilia A
-
Oct 16, 2026, 12:40Edward Lee Carter: How Factor XI Inhibition Could Transform Anticoagulation Therapy
-
Oct 16, 2026, 12:40Marc Carrier: Looking Ahead to ISTH 2027 in Vancouver
-
Oct 16, 2026, 12:30Bob Lempke: How One Blood Donation Can Save Up to Three Lives
-
Oct 16, 2026, 12:30Why VWF Therapies Belong on the EU Critical Medicines List – EHC